|
|
|
PROTOCOL SPECIFIC MATERIALS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Visit 1 - 2 weeks post biopsy, prior to treatment
|
|
Visit 2 - 5-10 days after tx initiation
|
|
|
Visit 3 - Mid therapy (prior to chemo regimen change)
DV -- Visit 3 Evaluation
Visit 4 - Within 3 weeks completion of tx, prior to surgery
DV -- Visit 4 Evaluation
TX - Chemotherapy Treatment
Post Surgery
SP - Surgical Pathology
End of Study
DS - End of Study Disposition
Additional Forms
AE - Adverse Events
PR - Protocol Variation
TI - Treatment Interruptions
TI - Treatment Interruptions Supplemental Form
MM - SOC Mammography Interpretation
MR - SOC MRI Interpretation
US - SOC Ultrasound Interpretation
TP - Chemotherapy Plan Supplemental Form TP Instructions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For additional information regarding Adverse Events,
please visit ACRIN’s Protocol Development and Regulatory Resources page: www.acrin.org/pdrc.aspx [Site Link]
|
|
|
|
|
|
|
|
|
 |
|
|
|
|